BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1827524)

  • 1. Trisomic pregnancies have normal human chorionic gonadotropin bioactivity.
    Kratzer PG; Golbus MS; Finkelstein DE; Taylor RN
    Prenat Diagn; 1991 Jan; 11(1):1-6. PubMed ID: 1827524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-trimester aneuploidy screening using serum human chorionic gonadotropin (hCG), free ahCG, and progesterone.
    Kratzer PG; Golbus MS; Monroe SE; Finkelstein DE; Taylor RN
    Prenat Diagn; 1991 Oct; 11(10):751-63. PubMed ID: 1724801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses.
    Bogart MH; Golbus MS; Sorg ND; Jones OW
    Prenat Diagn; 1989 Jun; 9(6):379-84. PubMed ID: 2762231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstetrical complications associated with abnormal maternal serum markers analytes.
    Gagnon A; Wilson RD;
    J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal urinary beta-core hCG in chromosomally abnormal pregnancies in the first trimester.
    Kornman LH; Morssink LP; Wortelboer MJ; Beekhuis JR; De Wolf BT; Pratt JJ; Mantingh A
    Prenat Diagn; 1997 Feb; 17(2):135-9. PubMed ID: 9061761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosomal disorders. The Dutch Working Party on Prenatal Diagnosis.
    Van Lith JM
    Prenat Diagn; 1992 Jun; 12(6):495-504. PubMed ID: 1387477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-trimester maternal serum alpha-fetoprotein and chorionic gonadotropin in aneuploid pregnancies.
    Johnson A; Cowchock FS; Darby M; Wapner R; Jackson LG
    Prenat Diagn; 1991 Jul; 11(7):443-50. PubMed ID: 1721715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum parameters and nuchal translucency in first trimester screening for fetal chromosomal abnormalities.
    Zimmermann R; Hucha A; Savoldelli G; Binkert F; Achermann J; Grudzinskas JG
    Br J Obstet Gynaecol; 1996 Oct; 103(10):1009-14. PubMed ID: 8863700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum hCG and fetal nuchal translucency thickness for the prediction of fetal trisomies in the first trimester of pregnancy.
    Brizot ML; Snijders RJ; Butler J; Bersinger NA; Nicolaides KH
    Br J Obstet Gynaecol; 1995 Feb; 102(2):127-32. PubMed ID: 7538782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triploidy identified through second-trimester serum screening.
    Huang T; Alberman E; Wald N; Summers AM
    Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum hCG and SP1 in pregnancies with fetal aneuploidy.
    Bartels I; Thiele M; Bogart MH
    Am J Med Genet; 1990 Oct; 37(2):261-4. PubMed ID: 2147362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy.
    Mock P; Kovalevskaya G; O'Connor JF; Campana A
    Hum Reprod; 2000 Oct; 15(10):2209-14. PubMed ID: 11006201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-trimester maternal serum human thyroid-stimulating hormone in chromosomally normal and Down syndrome pregnancies.
    Weinans MJ; Pratt JJ; de Wolf BT; Mantingh A
    Prenat Diagn; 2001 Sep; 21(9):723-5. PubMed ID: 11559906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroidogenesis patterns in common trisomies.
    Gillen-Goldstein J; Roque H; Young BK
    J Perinat Med; 2002; 30(2):132-6. PubMed ID: 12012633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fetal and maternal hCG concentration in aneuploid pregnancies.
    Abbas A; Chard T; Nicolaides K
    Br J Obstet Gynaecol; 1995 Jul; 102(7):561-3. PubMed ID: 7647060
    [No Abstract]   [Full Text] [Related]  

  • 19. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
    Benn PA
    Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
    Spencer K; Nicolaides KH
    BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.